Log in to your Inderes Free account to see all free content on this page.
Initiator Pharma
6.44
SEK
-0.92 %
Less than 1K followers
INIT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-0.92%
-9.93%
-5.99%
-5.99%
-12.97%
-29.23%
-20.69%
+19.23%
+43.57%
Initiator Pharma is a biotechnology company. Today, the main focus is to develop drug candidates to be used in treatment of erectile dysfunction in men. The company currently has pharmaceuticals in clinical stage testing for patients that do not respond on PDE5i pharmaceuticals. Initiator Pharma was created as a spin-off from Saniona and is today based in Åbyhøj.
Read moreMarket cap
361.66M SEK
Turnover
148.05K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
9.5.
2025
Interim report Q1'25
23.5.
2025
General meeting '25
22.8.
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
Carnegie Access: Initiator Pharma: Highlights from Carnegie’s Healthcare Conference
Carnegie Access: Initiator Pharma: Partner collaboration is at the top of the agenda – Q4(24) review
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio